4.7 Article

Hippo Reprograms the Transcriptional Response to Ras Signaling

期刊

DEVELOPMENTAL CELL
卷 42, 期 6, 页码 667-+

出版社

CELL PRESS
DOI: 10.1016/j.devcel.2017.08.013

关键词

-

资金

  1. Swiss National Science Foundation [PP00P3_150682]
  2. Flanders Research Foundation (FWO)
  3. FWO [G.0954.16, G.0306.16, G.0640.13, G.0791.14, G.0C04.17]
  4. Special Research Fund (BOF) KU Leuven [PF/10/016, OT/13/103]
  5. Foundation Against Cancer grant [2012-F2]
  6. ERC CoG [724226_cis-CONTROL]
  7. Stowers Institute for Medical Research
  8. NIH New Innovator Award [1DP2 OD004561-01]
  9. Flemish Agency for Innovation by Science and Technology
  10. Swiss National Science Foundation (SNF) [PP00P3_150682] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Hyperactivating mutations in Ras signaling are hallmarks of carcinomas. Ras signaling mediates cell fate decisions as well as proliferation during development. It is not known what dictates whether Ras signaling drives differentiation versus proliferation. Here we show that the Hippo pathway is critical for this decision. Loss of Hippo switches Ras activation from promoting cellular differentiation to aggressive cellular proliferation. Transcriptome analysis combined with genetic tests show that this excessive proliferation depends on the synergistic induction of Ras target genes. Using ChIPnexus, we find that Hippo signaling keeps Ras targets in check by directly regulating the expression of two key downstream transcription factors of Ras signaling: the ETS-domain transcription factor Pointed and the repressor Capicua. Our results highlight how independent signaling pathways can impinge on each other at the level of transcription factors, thereby providing a safety mechanism to keep proliferation in check under normal developmental conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据